|
|||||
|
|
– Orders decreased 5% year over year, but increased 5% sequentially
– Restructuring initiatives expected to achieve $1.5 million annualized savings by mid-2026
– Declared a quarterly cash dividend of $0.20 per share
LOS ANGELES, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and “quality of life” products under the NHT Global brand, today announced its financial results for the quarter ended September 30, 2025.
Third Quarter 2025 Financial Highlights
| 1 | Natural Health Trends defines Active Members as those that have placed at least one product order with the Company during the preceding twelve-month period. |
Year-to-Date 2025 Financial Highlights
Management Commentary
“The economic outlook in our largest market remains challenging in the near term. We are undertaking a major restructuring, which we expect will result in $1.5 million annualized savings. Our ongoing measures include optimizing our workforce and relocating product manufacturing to Asia. As part of these restructuring initiatives, we expect to incur a one-time charge of approximately $250,000 in the fourth quarter and anticipate a reduction in our quarterly cash dividend to $0.10 per share beginning in the first quarter next year,” commented Chris Sharng, President of Natural Health Trends Corp.
Mr. Sharng continued, “These actions will enable investments in new systems and technologies, including an AI-enabled marketing app and a member-interface business suite, as well as new marketing initiatives designed to drive member growth and engagement. By aligning costs with global sales performance, we are positioning the company for sustainable growth, profitability, and long-term value creation.”
Balance Sheet and Cash Flow
Third Quarter 2025 Financial Results Conference Call
Management will host a conference call to discuss the third quarter 2025 financial results today, Wednesday, November 5, 2025 at 11:30 a.m. Eastern Time. The conference call details are as follows:
| Date: | Wednesday, November 5, 2025 |
| Time: | 11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time |
| Dial-in: | 1-800-330-6730 |
| Participant ID: | 236986 |
For those unable to participate during the live broadcast, a replay of the call will be available on the Company's Investor Relations website at https://ir.naturalhealthtrendscorp.
About Natural Health Trends Corp.
Natural Health Trends Corp. (NASDAQ: NHTC) is an international direct-selling and e-commerce company operating through its subsidiaries throughout Asia, the Americas, and Europe. The Company markets premium quality personal care products under the NHT Global brand. Additional information can be found on the Company’s website at www.naturalhealthtrendscorp.com.
Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 -- Forward-looking statements in this press release do not constitute guarantees of future performance. Forward-looking statements in this press release include statements relating to the anticipated effect of restructuring activities, including expected operational efficiencies and cost savings resulting therefrom, statements regarding technology investments, future growth and profitability, and statements relating to future dividends, the declaration and payment of which will be at the sole discretion of the Company's Board of Directors. Such forward-looking statements are subject to risks and uncertainties that could cause the Company’s actual results to differ materially from those anticipated. Such risks and uncertainties include the risks and uncertainties detailed under the caption “Risk Factors” in Natural Health Trends Corp.’s Annual Report on Form 10-K filed on February 21, 2025 with the Securities and Exchange Commission (SEC), as well as in subsequent reports filed this year with the SEC. The Company assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.
| NATURAL HEALTH TRENDS CORP. CONSOLIDATED BALANCE SHEETS (In thousands, except share data) | |||||||
| September 30, 2025 | December 31, 2024 | ||||||
| (Unaudited) | |||||||
| ASSETS | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 14,336 | $ | 13,533 | |||
| Marketable securities | 17,672 | 30,407 | |||||
| Inventories | 2,154 | 3,272 | |||||
| Other current assets | 3,726 | 3,771 | |||||
| Total current assets | 37,888 | 50,983 | |||||
| Property and equipment, net | 170 | 190 | |||||
| Operating lease right-of-use assets | 2,031 | 2,498 | |||||
| Restricted cash | 35 | 34 | |||||
| Deferred tax asset | 246 | 382 | |||||
| Other assets | 1,881 | 1,272 | |||||
| Total assets | $ | 42,251 | $ | 55,359 | |||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
| Current liabilities: | |||||||
| Accounts payable | $ | 1,011 | $ | 895 | |||
| Income taxes payable | 7 | 4,908 | |||||
| Accrued commissions | 1,751 | 2,021 | |||||
| Other accrued expenses | 1,484 | 1,425 | |||||
| Deferred revenue | 6,011 | 6,428 | |||||
| Amounts held in eWallets | 2,977 | 3,286 | |||||
| Operating lease liabilities | 991 | 1,127 | |||||
| Other current liabilities | 523 | 709 | |||||
| Total current liabilities | 14,755 | 20,799 | |||||
| Deferred tax liability | 173 | 174 | |||||
| Operating lease liabilities | 1,175 | 1,514 | |||||
| Total liabilities | 16,103 | 22,487 | |||||
| Stockholders’ equity: | |||||||
| Preferred stock | — | — | |||||
| Common stock | 13 | 13 | |||||
| Additional paid-in capital | 85,004 | 84,901 | |||||
| Accumulated deficit | (33,547 | ) | (26,344 | ) | |||
| Accumulated other comprehensive loss | (925 | ) | (1,301 | ) | |||
| Treasury stock, at cost | (24,397 | ) | (24,397 | ) | |||
| Total stockholders’ equity | 26,148 | 32,872 | |||||
| Total liabilities and stockholders’ equity | $ | 42,251 | $ | 55,359 | |||
| NATURAL HEALTH TRENDS CORP. CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (In thousands, except per share data) | |||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Net sales | $ | 9,477 | $ | 10,691 | $ | 30,027 | $ | 32,117 | |||||||
| Cost of sales | 2,490 | 2,765 | 7,880 | 8,376 | |||||||||||
| Gross profit | 6,987 | 7,926 | 22,147 | 23,741 | |||||||||||
| Operating expenses: | |||||||||||||||
| Commissions expense | 3,876 | 4,333 | 12,376 | 13,022 | |||||||||||
| Selling, general and administrative expenses | 3,606 | 3,868 | 10,944 | 11,597 | |||||||||||
| Total operating expenses | 7,482 | 8,201 | 23,320 | 24,619 | |||||||||||
| Loss from operations | (495 | ) | (275 | ) | (1,173 | ) | (878 | ) | |||||||
| Other income, net | 206 | 441 | 1,019 | 1,523 | |||||||||||
| Income (loss) before income taxes | (289 | ) | 166 | (154 | ) | 645 | |||||||||
| Income tax provision | 142 | 131 | 140 | 249 | |||||||||||
| Net income (loss) | $ | (431 | ) | $ | 35 | $ | (294 | ) | $ | 396 | |||||
| Net income (loss) per common share: | |||||||||||||||
| Basic | $ | (0.04 | ) | $ | 0.00 | $ | (0.03 | ) | $ | 0.03 | |||||
| Diluted | $ | (0.04 | ) | $ | 0.00 | $ | (0.03 | ) | $ | 0.03 | |||||
| Weighted average common shares outstanding: | |||||||||||||||
| Basic | 11,500 | 11,471 | 11,493 | 11,464 | |||||||||||
| Diluted | 11,500 | 11,490 | 11,493 | 11,488 | |||||||||||
| NATURAL HEALTH TRENDS CORP. CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (In thousands) | |||||||
| Nine Months Ended September 30, | |||||||
| 2025 | 2024 | ||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||
| Net income (loss) | $ | (294 | ) | $ | 396 | ||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |||||||
| Depreciation and amortization | 87 | 100 | |||||
| Net accretion of marketable securities | (317 | ) | (350 | ) | |||
| Share-based compensation | 103 | 109 | |||||
| Noncash lease expense | 852 | 825 | |||||
| Deferred income taxes | 139 | 62 | |||||
| Changes in assets and liabilities: | |||||||
| Inventories | 1,161 | 619 | |||||
| Other current assets | 682 | (110 | ) | ||||
| Other assets | (601 | ) | (250 | ) | |||
| Accounts payable | 114 | (441 | ) | ||||
| Income taxes payable | (4,901 | ) | (3,738 | ) | |||
| Accrued commissions | (314 | ) | (34 | ) | |||
| Other accrued expenses | 44 | 179 | |||||
| Deferred revenue | (422 | ) | 641 | ||||
| Amounts held in eWallets | (307 | ) | (501 | ) | |||
| Operating lease liabilities | (858 | ) | (851 | ) | |||
| Other current liabilities | (206 | ) | (111 | ) | |||
| Net cash used in operating activities | (5,038 | ) | (3,455 | ) | |||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||
| Purchases of property and equipment | (63 | ) | (37 | ) | |||
| Purchases of marketable securities | (39,011 | ) | (44,839 | ) | |||
| Proceeds from maturities of marketable securities | 51,619 | 21,786 | |||||
| Net cash provided by (used in) investing activities | 12,545 | (23,090 | ) | ||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||
| Dividends paid | (6,909 | ) | (6,909 | ) | |||
| Net cash used in financing activities | (6,909 | ) | (6,909 | ) | |||
| Effect of exchange rates on cash, cash equivalents and restricted cash | 206 | 174 | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | 804 | (33,280 | ) | ||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period | 13,567 | 56,217 | |||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period | $ | 14,371 | $ | 22,937 | |||
| SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES: | |||||||
| Right-of-use assets obtained in exchange for operating lease liabilities | $ | (83 | ) | $ | 191 | ||
CONTACT:
Scott Davidson
Senior Vice President and Chief Financial Officer
Natural Health Trends Corp.
Tel (U.S.): 310-541-0888
[email protected]

| Nov-05 | |
| Nov-05 | |
| Oct-29 | |
| Aug-08 | |
| Aug-07 | |
| Aug-04 | |
| Jul-31 | |
| Jul-30 | |
| Jul-23 | |
| May-27 | |
| May-23 | |
| May-05 | |
| May-01 | |
| May-01 | |
| Apr-30 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite